Conditional Effects of Lifetime Alcohol Consumption on Methamphetamine-Associated Neurocognitive Performance.


Journal

Journal of the International Neuropsychological Society : JINS
ISSN: 1469-7661
Titre abrégé: J Int Neuropsychol Soc
Pays: England
ID NLM: 9503760

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 11 6 2019
medline: 10 9 2020
entrez: 11 6 2019
Statut: ppublish

Résumé

Methamphetamine (MA) dependence contributes to neurotoxicity and neurocognitive deficits. Although combined alcohol and MA misuse is common, how alcohol consumption relates to neurocognitive performance among MA users remains unclear. We hypothesized that alcohol and MA use would synergistically diminish neurocognitive functioning, such that greater reported alcohol consumption would exert larger negative effects on neurocognition among MA-dependent individuals compared to MA-nonusing persons. Eighty-seven MA-dependent (MA+) and 114 MA-nonusing (MA-) adults underwent neuropsychological and substance use assessments. Linear and logistic regressions examined the interaction between MA status and lifetime average drinks per drinking day on demographically corrected global neurocognitive T scores and impairment rates, controlling for recent alcohol use, lifetime cannabis use, WRAT reading performance, and lifetime depression. MA+ displayed moderately higher rates of impairment and lower T scores compared to MA-. Lifetime alcohol use significantly interacted with MA status to predict global impairment (ORR = 0.70, p = .003) such that greater lifetime alcohol use increased likelihood of impairment in MA-, but decreased likelihood of impairment in MA+. Greater lifetime alcohol use predicted poorer global T scores among MA- (b = -0.44, p = .030) but not MA+ (b = 0.08, p = .586). Contrary to expectations, greater lifetime alcohol use related to reduced risk of neurocognitive impairment among MA users. Findings are supported by prior research identifying neurobiological mechanisms by which alcohol may attenuate stimulant-driven vasoconstriction and brain thermotoxicity. Replication and examination of neurophysiologic mechanisms underlying alcohol use in the context of MA dependence are warranted to elucidate whether alcohol confers a degree of neuroprotection.

Identifiants

pubmed: 31179969
pii: S1355617719000493
doi: 10.1017/S1355617719000493
pmc: PMC6733657
mid: NIHMS1527285
doi:

Substances chimiques

Central Nervous System Depressants 0
Central Nervous System Stimulants 0
Ethanol 3K9958V90M
Methamphetamine 44RAL3456C

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

787-799

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA035736
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA026334
Pays : United States
Organisme : NIAAA NIH HHS
ID : T32 AA013525
Pays : United States
Organisme : NIA NIH HHS
ID : F31 AG064989
Pays : United States
Organisme : NIDA NIH HHS
ID : P50 DA026306
Pays : United States
Organisme : NIDA NIH HHS
ID : K24 DA040550
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH062512
Pays : United States
Organisme : NIDA NIH HHS
ID : P01 DA012065
Pays : United States

Références

J Neuropsychiatry Clin Neurosci. 1999 Summer;11(3):361-9
pubmed: 10440013
Am J Epidemiol. 1999 Sep 15;150(6):580-9
pubmed: 10489997
Drug Alcohol Depend. 2000 Apr 1;59(1):89-93
pubmed: 10706978
Neurology. 2000 Jun 27;54(12):2285-92
pubmed: 10881254
Psychiatry Res. 2002 Jun 15;114(2):65-79
pubmed: 12036507
Drug Alcohol Depend. 2002 Sep 1;68(1):95-104
pubmed: 12167555
J Neurotrauma. 2002 Dec;19(12):1597-608
pubmed: 12542860
Alcohol Clin Exp Res. 2003 Mar;27(3):457-64
pubmed: 12658111
J Neuropsychiatry Clin Neurosci. 2003 Spring;15(2):215-20
pubmed: 12724464
J Neurosci. 2003 May 1;23(9):3924-9
pubmed: 12736362
Pharmacol Biochem Behav. 1992 Jul;42(3):389-400
pubmed: 1357672
FASEB J. 2003 Oct;17(13):1775-88
pubmed: 14519657
Neuropsychology. 2004 Jan;18(1):152-62
pubmed: 14744198
J Int Neuropsychol Soc. 2004 Jan;10(1):1-14
pubmed: 14751002
Neuropsychologia. 2004;42(11):1447-58
pubmed: 15246283
Am J Epidemiol. 2004 Aug 1;160(3):240-7
pubmed: 15257997
Alcohol Res Health. 2003;27(2):125-33
pubmed: 15303622
Drug Alcohol Depend. 2004 Nov 11;76(2):181-90
pubmed: 15488342
J Clin Exp Neuropsychol. 2004 May;26(3):307-19
pubmed: 15512922
Alcohol Clin Exp Res. 1992 Feb;16(1):75-81
pubmed: 1558306
J Urban Health. 2005 Mar;82(1 Suppl 1):i18-25
pubmed: 15738324
Alcohol Clin Exp Res. 2005 May;29(5):902-8
pubmed: 15897737
Am J Addict. 2005 Mar-Apr;14(2):166-78
pubmed: 16019965
Addiction. 2005 Sep;100(9):1280-90
pubmed: 16128717
Alcohol. 2005 Aug;37(1):53-8
pubmed: 16472719
Psychopharmacology (Berl). 2006 Apr;185(3):327-38
pubmed: 16518646
Electroencephalogr Clin Neurophysiol. 1990 Sep-Oct;77(5):362-75
pubmed: 1697528
J Clin Exp Neuropsychol. 2007 Feb;29(2):155-9
pubmed: 17365250
Neuropsychol Rev. 2007 Sep;17(3):275-97
pubmed: 17694436
Synapse. 2008 Feb;62(2):91-100
pubmed: 17992686
Neuropsychopharmacology. 2009 Apr;34(5):1112-22
pubmed: 18496524
Neurocrit Care. 2009;10(3):295-305
pubmed: 19132558
Drug Alcohol Depend. 2010 Jan 15;106(2-3):154-63
pubmed: 19815352
Int Rev Neurobiol. 2009;88:65-100
pubmed: 19897075
J Neurosci. 2010 Mar 17;30(11):3876-85
pubmed: 20237258
Addict Biol. 1999 Apr;4(2):127-40
pubmed: 20575779
Int J Environ Res Public Health. 2010 Apr;7(4):1540-57
pubmed: 20617045
J Gerontol B Psychol Sci Soc Sci. 2011 Jan;66(1):39-47
pubmed: 20937708
Neuroimage. 2011 Feb 14;54(4):3067-75
pubmed: 21040792
Int J Physiol Pathophysiol Pharmacol. 2011;3(1):48-56
pubmed: 21258656
J Clin Exp Neuropsychol. 2011 Aug;33(7):793-804
pubmed: 21547817
PLoS One. 2011 Apr 27;6(4):e19258
pubmed: 21556365
Psychopharmacology (Berl). 2012 Jan;219(1):191-204
pubmed: 21748253
Neuropsychiatr Dis Treat. 2011;7:465-84
pubmed: 21857787
Neuropsychopharmacology. 2012 Feb;37(3):586-608
pubmed: 22089317
Addict Biol. 2013 Mar;18(2):203-13
pubmed: 22264351
J Anal Toxicol. 2012 Jan-Feb;36(1):30-5
pubmed: 22290750
Clin Neuropsychol. 2012;26(6):894-908
pubmed: 22708483
Neuropsychopharmacology. 2013 Jan;38(2):259-74
pubmed: 22948978
Alcohol Res Health. 2010;33(1-2):127-43
pubmed: 23579943
Pharmacol Rev. 2013 Dec 16;66(1):193-221
pubmed: 24344115
Drug Alcohol Depend. 2014 Sep 1;142:127-32
pubmed: 24975477
Front Psychiatry. 2014 Jul 16;5:78
pubmed: 25076914
J Addict Med. 2014 Sep-Oct;8(5):368-76
pubmed: 25187977
Handb Clin Neurol. 2014;125:183-210
pubmed: 25307576
Behav Neurol. 2015;2015:103969
pubmed: 25861156
Front Neurosci. 2015 May 05;9:156
pubmed: 25999807
J Cereb Blood Flow Metab. 2016 Mar;36(3):539-54
pubmed: 26661236
Crit Care. 2016 Jul 14;20(1):199
pubmed: 27411704
J Addict Res Ther. 2016 Jun;7(3):
pubmed: 27478679
J Addict Dis. 2017 Jan-Mar;36(1):38-47
pubmed: 27719514
Neuropsychology. 2017 Mar;31(3):311-318
pubmed: 28054825
BMJ. 2017 Jun 6;357:j2353
pubmed: 28588063
Int J Drug Policy. 2017 Nov;49:32-40
pubmed: 28888099
Alcohol Res. 2017;38(2):219-241
pubmed: 28988575
J Consult Clin Psychol. 1987 Jun;55(3):310-24
pubmed: 3597943
Stroke. 1987 Jan-Feb;18(1):268-71
pubmed: 3810763
Can Med Assoc J. 1966 Mar 5;94(10):478-84
pubmed: 5324976
Addiction. 1995 Mar;90(3):351-9
pubmed: 7735020
Clin Pharmacol Ther. 1995 May;57(5):559-68
pubmed: 7768079
Eur Neurol. 1994;34(1):16-22
pubmed: 8137834
Clin Chim Acta. 1996 Mar 15;246(1-2):77-89
pubmed: 8814972
J Pharmacol Exp Ther. 1997 Oct;283(1):164-76
pubmed: 9336321
J Neurotrauma. 1998 Feb;15(2):105-15
pubmed: 9512086
J Int Neuropsychol Soc. 1999 Jan;5(1):10-9
pubmed: 9989019

Auteurs

Rowan Saloner (R)

San Diego State University/University of California, San Diego Joint Doctoral Program in Clinical Psychology, 6363 Alvarado Court, Suite 102, San Diego, CA 92120, USA.
Department of Psychiatry, University of California, HIV Neurobehavioral Research Program, 220 Dickinson Street, Suite B, San Diego, CA 92103, USA.

Emily W Paolillo (EW)

San Diego State University/University of California, San Diego Joint Doctoral Program in Clinical Psychology, 6363 Alvarado Court, Suite 102, San Diego, CA 92120, USA.
Department of Psychiatry, University of California, HIV Neurobehavioral Research Program, 220 Dickinson Street, Suite B, San Diego, CA 92103, USA.

Anya Umlauf (A)

Department of Psychiatry, University of California, HIV Neurobehavioral Research Program, 220 Dickinson Street, Suite B, San Diego, CA 92103, USA.

David J Moore (DJ)

Department of Psychiatry, University of California, HIV Neurobehavioral Research Program, 220 Dickinson Street, Suite B, San Diego, CA 92103, USA.

Robert K Heaton (RK)

Department of Psychiatry, University of California, HIV Neurobehavioral Research Program, 220 Dickinson Street, Suite B, San Diego, CA 92103, USA.

Igor Grant (I)

Department of Psychiatry, University of California, HIV Neurobehavioral Research Program, 220 Dickinson Street, Suite B, San Diego, CA 92103, USA.

Mariana Cherner (M)

Department of Psychiatry, University of California, HIV Neurobehavioral Research Program, 220 Dickinson Street, Suite B, San Diego, CA 92103, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH